<img height="1" width="1" src="https://www.facebook.com/tr?id=333518893979624&amp;ev=PageView&amp;noscript=1">
Avinger

Smoking Publications

Smoking cessation is associated with decreased mortality and improved amputation-free survival among patients with symptomatic peripheral artery disease. 

Armstrong, et al.  J Vasc Surg 2014;60:1565-71

 

The Relationship of Cigarette Smoking to Peripheral Arterial Disease

Lu, et al. Rev Cardiovasc Med. 2004;5(4):189-193

 

Risk factors associated with the development of peripheral arterial disease in smokers: a case control study.

Powell, et al. Atherosclerosis. 1997;129:41–48.

 

Cardiovascular toxicity of nicotine: implications for nicotine replacement therapy.

Benowitz, et al. J Am Coll Cardiol. 1997 Jun;29(7):1422-31.

 

Cigarette smoking and peripheral arterial occlusive disease.

Cole, et al. Surgery. 1993;114:753–756

 

The cardiovascular pathology of smoking.

McGill, HC., The cardiovascular pathology of smoking. Am Heart J. 1988;115:250–257.

 

Cessation of smoking in patients with intermittent claudication. Effects on the risk of peripheral vascular complications, myocardial infarction and mortality.

Jonason, et al. Acta Med Scand. 1987;221(3):253-60.

 

Latest perspectives on cigarette smoking and cardiovascular disease: the Framingham study.

Kannel, et al. J Card Rehabil. 1984;4:267–77.

 

The effect of cessation of smoking on the accumulative survival rates of patients with symptomatic peripheral vascular disease.

Faulkner, et al. Med J Aust. 1983 Mar 5;1(5):217-9.

 

© 2022 Avinger. All Rights Reserved

  • Terms of Use
  • Policies

United States